LOC730060 Inhibitors

Triciribine and Dasatinib, for instance, target AKT and Src family kinases, respectively, both of which are critical components of cell signaling and could affect LOC730060 if it is a part of these pathways. GO6983 and PD0325901, by inhibiting PKC and MEK, can alter the phosphorylation states and signaling cascades that might impinge upon LOC730060's function.

Roscovitine's inhibition of CDKs and SB431542's targeting of the TGF-beta receptor provide means by which cell cycle progression and growth factor signaling can be modulated, potentially affecting the role of LOC730060 in these processes. Gefitinib's action on EGFR and ZM-447439's on Aurora kinases can influence signal transduction related to cell growth and division, which may extend to the modulation of LOC730060. Y-27632, as a ROCK inhibitor, and 5-Azacytidine, by its action on DNA methyltransferases, can alter cytoskeletal dynamics and gene expression patterns, respectively, thereby possibly influencing the cellular context within which LOC730060 operates. Alsterpaullone's inhibition of GSK-3beta can affect the Wnt signaling pathway, while 4-Methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibition of NF-kB signaling can alter transcriptional regulation, both of which are processes that could potentially modulate the activity or expression of LOC730060.